Table: Aska Pharmaceutical -2018/19 group results

ASKA Pharmaceutical Holdings

10/05/2019 07:01

May 10 (Reuters)- 
          Aska Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           46.71           48.94          53.00                 
               (-4.6 pct)      (+0.9 pct)     (+13.5 pct)              
  Operating        1.78            2.82           2.00                 
               (-36.9 pct)     (+57.4 pct)    (+12.2 pct)              
  Recurring        1.98            3.07           2.10                 
               (-35.6 pct)     (+53.5 pct)    (+6.1 pct)               
  Net
  Net              1.74            2.39           1.00                 
               (-27.0 pct)     (-18.9 pct)    (-42.7 pct)              
  EPS           61.81 yen       84.80 yen      35.41 yen               
  Ann Div       14.00 yen       14.00 yen      14.00 yen               
  -Q2 Div       7.00 yen        7.00 yen       7.00 yen                
  -Q4 Div       7.00 yen        7.00 yen       7.00 yen                
  
  NOTE - Aska Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T